Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Identification and characterization of the Myb-inducible promoter of the chicken adenosine receptor 2B gene

Abstract

Numerous studies have shown that the retroviral oncogene v-myb encodes a transcription factor (v-Myb) which interferes with the differentiation program of myelomonocytic cells. It is generally thought that v-Myb deregulates the expression of specific target genes and thereby causes transformation of these cells. By using an estrogen-inducible version of v-Myb we have previously identified the gene for the chicken A2B adenosine receptor (A2B-AR), a member of the seven-pass transmembrane receptor superfamily, as a bona fide target gene for v-Myb. The chicken A2B-AR gene is expressed in v-myb transformed myeloblasts as well as in c-myb expressing erythroblasts, offering the opportunity to study how Myb transcription factors activate a target gene in two different hematopoietic lineages. Here, we report the characterization of the promoter of the A2B-AR gene. We show that the A2B-AR promoter region contains an exceptionally large number of Myb binding sites, many of which contribute to the Myb-inducibility of the promoter. The same sites were required for promoter activity in myelomonocytic and erythroid cells. In contrast to the promoters of other Myb target genes the A2B-AR promoter was not activated synergistically by Myb and other lineage-specific transcription factors that have been identified as Myb cooperation partners before. Taken together, our data suggest that the activation of the A2B-AR promoter by Myb depends on the simultaneous binding of a large number of Myb molecules.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Biedenkapp H, Borgmeyer U, Sippel AE, Klempnauer K-H . 1988 Nature 355: 835–837

  • Burk O, Mink S, Ringwald M, Klempnauer K-H . 1993 EMBO J. 12: 2027–2038

  • Burk O, Worpenberg S, Haenig B, Klempnauer K-H . 1997 EMBO J. 16: 1371–1380

  • Burk O, Klempnauer K-H . 1999 Biochem. Biophys. Acta 1446: 243–252

  • Cao Z, Umek RM, McKnight SL . 1991 Genes Dev. 5: 1538–1552

  • Chen L-C, Courtneidge SA, Bishop JM . 1983 Mol. Cell. Biol. 3: 1077–1085

  • Dini PW, Lipsick JS . 1993 Mol. Cell. Biol. 13: 7334–7348

  • Frampton J, Kouzarides T, Döderlein G, Graf T, Weston K . 1993 EMBO J. 12: 1333–1341

  • Frampton J, Ramqvist T, Graf T . 1996 Genes Dev. 10: 2720–2731

  • Grässer FA, Graf T, Lipsick JS . 1991 Mol. Cell. Biol. 11: 3987–3996

  • Hernandez-Munain C, Krangel MS . 1995 Mol. Cell. Biol. 15: 3090–3099

  • Hogg A, Schirm S, Nakagoshi H, Bartley P, Ishii S, Bishop JM, Gonda TJ . 1997 Oncogene 15: 2885–2898

  • Ibanez CE, Lipsick JS . 1990 Mol. Cell. Biol. 10: 2285–2293

  • Introna M, Golay J, Frampton J, Nakano T, Ness SA, Graf T . 1990 Cell 63: 1287–1297

  • Katz S, Kowenz-Leutz E, Müller C, Meese K, Ness SA, Leutz A . 1993 EMBO J. 12: 1321–1332

  • Klempnauer KH, Bishop JM . 1983 J. Virol. 48: 565–572

  • Klempnauer K-H, Gonda TJ, Bishop JM . 1982 Cell 31: 453–463

  • Klempnauer K-H, Ramsay G, Bishop JM, Moscovici MG, Moscovici C, McGrath JP, Levinson AD . 1983 Cell 33: 345–355

  • Klempnauer K-H, Arnold H, Biedenkapp H . 1989 Genes Dev. 3: 1582–1589

  • Kowenz-Leutz E, Herr P, Niss K, Leutz A . 1997 Cell 91: 185–195

  • Lane T, Ibanez C, Garcia A, Graf T, Lipsick J . 1990 Mol. Cell. Biol. 10: 2591–2598

  • Lekstrom-Himes J, Xanthopoulos KG . 1998 J. Biol. Chem. 273: 28545–28548

  • Lipsick JS, Wang D-M . 1999 Oncogene 18: 3047–3055

  • Mink S, Kerber U, Klempnauer K-H . 1996 Mol. Cell. Biol. 16: 1316–1325

  • Mink S, Haenig B, Klempnauer K-H . 1997 Mol. Cell. Biol. 17: 6609–6617

  • Mink S, Jaswal S, Burk O, Klempnauer K-H . 1999 Biochim. Biophys. Acta 1447: 175–184

  • Moscovici C, Moscovici MG, Jiminez H, Lai MMC, Hayman MJ, Vogt PK . 1977 Cell 11: 95–103

  • Natsuka A, Akira S, Nishio Y, Hashimoto S, Sugita T, Isshiki H, Kishimoto T . 1992 Blood 79: 460–466

  • Ness SA . 1996 Biochim. Biophys. Acta 1288: F123–F139

  • Ness SA, Marknell A, Graf T . 1989 Cell 59: 1115–1125

  • Ness SA, Kowentz-Leutz E, Casini T, Graf T, Leutz A . 1993 Genes Dev. 7: 749–759

  • Nishina Y, Nakagoshi H, Imamoto F, Gonda TJ, Ishii S . 1989 Nucleic Acids Res. 17: 107–117

  • Oehler T, Arnold H, Biedenkapp H, Klempnauer K-H . 1990 Nucleic Acids Res. 18: 1703–1710

  • Oelgeschläger M, Nuchprayoon I, Lüscher B, Friedman AD . 1996 Mol. Cell. Biol. 16: 4717–4725

  • Oh I-H, Reddy EP . 1999 Oncogene 18: 3017–3033

  • Reizis B, Leder P . 2001 J. Exp. Med. 194: 979–990

  • Schlichter U, Burk O, Worpenberg S, Klempnauer K-H . 2001a Oncogene 20: 231–239

  • Schlichter U, Kattmann D, Appl H, Miethe J, Brehmer-Fastnacht A, Klempnauer K-H . 2001b Biochem. Biophys. Acta 1520: 99–104

  • Scott LM, Civin CI, Rorth P, Friedman AD . 1992 Blood 80: 1725–1735

  • Siu G, Wurster AL, Lipsick JS, Hedrick SM . 1992 Mol. Cell. Biol. 12: 1592–1604

  • Taylor D, Badiani P, Weston K . 1996 Genes Dev. 10: 2732–2744

  • Wang QF, Lauring J, Schlissel MS . 2000 Mol. Cell. Biol. 20: 9203–9211

  • Weston K . 1998 Curr. Opin. Genet. Dev. 8: 76–81

  • Weston K, Bishop JM . 1989 Cell 58: 85–93

  • Worpenberg S, Burk O, Klempnauer K-H . 1997 Oncogene 15: 213–221

  • Zhang X, Xing G, Fraizer GC, Saunders GF . 1997 J. Biol. Chem. 272: 29272–29280

Download references

Acknowledgements

We thank O Burk and S Worpenberg who performed the initial screening and characterization of genomic A2B-AR clones. This work was supported by grants from the DFG (GRK233/1−97 and SFB 291/A13) and the Fonds der chemischen Industrie.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karl-Heinz Klempnauer.

Additional information

The accession number for the A2B-AR promoter sequence is AF508797.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kattmann, D., Klempnauer, KH. Identification and characterization of the Myb-inducible promoter of the chicken adenosine receptor 2B gene. Oncogene 21, 4663–4673 (2002). https://doi.org/10.1038/sj.onc.1205579

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205579

Keywords

This article is cited by

Search

Quick links